<code id='CAD6CB5568'></code><style id='CAD6CB5568'></style>
    • <acronym id='CAD6CB5568'></acronym>
      <center id='CAD6CB5568'><center id='CAD6CB5568'><tfoot id='CAD6CB5568'></tfoot></center><abbr id='CAD6CB5568'><dir id='CAD6CB5568'><tfoot id='CAD6CB5568'></tfoot><noframes id='CAD6CB5568'>

    • <optgroup id='CAD6CB5568'><strike id='CAD6CB5568'><sup id='CAD6CB5568'></sup></strike><code id='CAD6CB5568'></code></optgroup>
        1. <b id='CAD6CB5568'><label id='CAD6CB5568'><select id='CAD6CB5568'><dt id='CAD6CB5568'><span id='CAD6CB5568'></span></dt></select></label></b><u id='CAD6CB5568'></u>
          <i id='CAD6CB5568'><strike id='CAD6CB5568'><tt id='CAD6CB5568'><pre id='CAD6CB5568'></pre></tt></strike></i>

          Home / comprehensive / comprehensive

          comprehensive


          comprehensive

          author:fashion    Page View:172
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In